Brown JP, Prince RL, Deal C, et al. Comparison of the effect of denosumab, alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial. J Bone Miner Res. 2009, 24(1):153-161. doi: 10.1359/jbmr.080901.
Advertisement
Articles by Brown JP, Prince RL, Deal C, et al. Comparison of the effect of denosumab, alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial. J Bone Miner Res. 2009, 24(1):153-161. doi: 10.1359/jbmr.080901.
Advertisement
Latest Updated Articles
- Study Summary: DECIDE
Published: June 29th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
OpenAI for Healthcare Aims to Streamline Clinical Workflows, Reduce Administrative Burden
2
Medical Debt Emerges as Risk Factor for Housing Instability
3
AbbVie Joins Trump Drug Pricing Effort, Pledges $100B in US R&D Investment
4
Smarter Vaccination Strategies Could Strengthen Future Influenza Preparedness: Marco del Riccio, MD
5
